"Yet, here we are, steamrolling along at $1.05. Ti

"Yet, here we are, steamrolling along at $1.05. Time the WORLD knows about CYDY!"

I think once the BLA gets submitted, we'll be pushing towards $2. And when we get the next signed license deal or positive news about the BTD, it will push it over the $2-$3 mark. At that time, we can uplist. After uplisting, the whole world might not know about us, but the tutes and investment community will know about us, and I think that will be the driving force of the share price in the short term. While submitting the BLA is important in the USA because we can't sell it "here" until we get FDA approval, I think approval by the CFDA and other countries will come much faster due to the coronavirus, and cancer treatment being a bonus to them. Given that we're still expecting FDA approval by the end of the year, I would expect gov't approval from other countries to be much sooner, and I think the european/asian market is much larger than ours. Personally, I don't think FDA approval is the critical path anymore as much as our ability to supply the drug when we get the approvals from other countries. I think that will determine how much revenue we can generate this year.

My comments are just my opinions and should NOT be taken as investment advice.